Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for antigens cd20
Most Correlated Studies
- CD20+ CD5+ Chronic Lymphocytic Leukemia (CLL) cells cultured with activated T cells or CD40L+ cells
- Antibody secreting cells CD19+/- and B cells CD20+/- purified from bone marrows
- Splenic B cells and bone marrow hematopoietic stem cells from USP3-/- mice
- Response to rituximab in follicular lymphoma
- B cells from healthy donors: naive, memory, B1 and plasmablast subsets
Most Relevant Literature
- Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen bindi…
- Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chr…
- Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.
- Secondary rituximab-associated versus primary immunodeficiencies: The enigmatic border.
- Screening, expression and characterization of anti-human CD20 nanobodies].
Most Relevant Clinical Trials
- A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Dise…
- An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of Differentiation Antigen 19/20(…
- A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal An…
- T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cel…
- Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Ly…
